Cardiologia

Estudo randomizado | Inibidor de SGLT2 empaglifozina em pacientes internados com insuficiência cardíaca aguda.

9 Mar, 2022 | 13:54h

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial – Nature Medicine

---

Diretriz da ACR/Vasculitis Foundation para o tratamento da doença de Kawasaki.

9 Mar, 2022 | 13:53h

2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease

---

Posicionamento científico | Fatores de risco relacionados à saúde mental e intervenções em pacientes com insuficiência cardíaca.

9 Mar, 2022 | 13:41h

Mental health-related risk factors and interventions in patients with heart failure: a position paper endorsed by the European Association of Preventive Cardiology (EAPC) – European Journal of Preventive Cardiology

 

Comentário no Twitter

📢#EAPC_ESC Position paper in #EJPC#MentalHealth & #HeartFailure – overview of the scientific evidence of #psychosocial aspects of #HF https://t.co/5Xr6500zWW#MentalHealthMatters #MentalHealthAwareness @frank_doyle4 @ma_hamer @HendrikSager @m_piepoli @SilCastelletti pic.twitter.com/DQyAob9y4s

— European Society of Cardiology Journals (@ESC_Journals) February 20, 2022

 

---

Ano de 2021 na medicina cardiovascular: exames de imagem.

9 Mar, 2022 | 13:29h

The year in cardiovascular medicine 2021: imaging – European Heart Journal

Conteúdos relacionados:

The year in cardiovascular medicine 2021: arrhythmias.

The year in cardiovascular medicine 2021: valvular heart disease.

The year in cardiovascular medicine 2021: diabetes and metabolic disorders.

The year in cardiovascular medicine 2021: heart failure and cardiomyopathies.

The year in cardiovascular medicine 2021: dyslipidemia.

Year in cardiovascular medicine: cardio-oncology 2020–21.

The year in cardiovascular medicine 2021: digital health and innovation.

---

Revisão | Cardiotoxicidade da terapia com antígeno quimérico receptor de célula T para malignidades avançadas.

9 Mar, 2022 | 13:28h

Cardiotoxicity from chimeric antigen receptor-T cell therapy for advanced malignancies – European Heart Journal

---

Diretriz Científica AHA | Interações medicamentosas na cárdio-oncologia.

8 Mar, 2022 | 18:41h

Cardio-Oncology Drug Interactions: A Scientific Statement From the American Heart Association – Circulation

---

Estudo randomizado | Rastreamento para fibrilação atrial em idosos por meio de ECG de derivação única não aumentou as taxas de detecção em 1 ano.

8 Mar, 2022 | 18:38h

Screening for Atrial Fibrillation in Older Adults at Primary Care Visits: the VITAL-AF Randomized Controlled Trial – Circulation (link to abstract – $ for full-text)

Conteúdos relacionados:

USPSTF Recommendation Statement: Still not enough evidence to recommend atrial fibrillation screening.

#ESCCongress – RCT: In individuals at risk for stroke, screening for atrial fibrillation using loop recorder resulted in a three-times increase in atrial fibrillation detection and anticoagulation initiation but did not reduce the risk of stroke or systemic arterial embolism.

#ESCCongress – RCT: Small benefit from systematic screening for atrial fibrillation in older adults – After a median follow-up of 6.9 y there were fewer events (stroke, embolism, bleeding, and death) in the intervention group (31·9%) vs. control group (33·0%).

Clinical Review: Screening and management of atrial fibrillation in primary care

---

Luta contra morte súbita cardíaca: necessidade de mudança de paradigma – Somar prevenção de curto prazo e ações preemptivas para a prevenção de longo prazo.

8 Mar, 2022 | 18:22h

Fighting against sudden cardiac death: need for a paradigm shift—Adding near-term prevention and pre-emptive action to long-term prevention – European Heart Journal

 

Comentário no Twitter

Fighting against #SuddenCardiacDeath: need for a paradigm shift—Adding near-term prevention and pre-emptive action to long-term prevention https://t.co/5xLeUAB9QD @escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes pic.twitter.com/IGzZ8dmLd6

— European Society of Cardiology Journals (@ESC_Journals) March 7, 2022

 

---

Impacto global da insuficiência cardíaca: revisão ampla e atualizada da epidemiologia.

8 Mar, 2022 | 18:00h

Global burden of heart failure: a comprehensive and updated review of epidemiology – Cardiovascular Research

 

Comentário no Twitter

Seeing the big picture🖼️

Assessing the global🌍burden of #HeartFailure❤️, from prevalence to cost & the #inequities faced by developing countries https://t.co/1klLCTMLTL@CVR_TomaszGuzik @DrMikeDrozd @glenpyle #epidemiology #PublicHealth #HF #CardiovascularResearch pic.twitter.com/XX9iV0C8Mj

— European Society of Cardiology Journals (@ESC_Journals) March 4, 2022

 

---

Estudo randomizado | Em pacientes com dor torácica estável com probabilidade intermediária pré-teste de doença arterial coronariana, uma estratégia inicial de diagnóstico angiográfico por TC resultou em riscos similares de eventos adversos cardiovasculares graves em comparação com a angiografia coronariana invasiva.

8 Mar, 2022 | 17:55h

CT or Invasive Coronary Angiography in Stable Chest Pain – New England Journal of Medicine (link para o resumo – $ para o texto completo)

Comentário: DISCHARGE Hailed as a Big Step Forward for CTA in Stable Chest Pain – TCTMD

 

Comentário no Twitter

Among patients referred for invasive coronary angiography because of stable chest pain and intermediate pretest probability of CAD, the risk of major adverse CV events was similar in the CT group and the ICA group. #ECR22 https://t.co/KnuQo0juxE pic.twitter.com/Sf70dqfgKP

— NEJM (@NEJM) March 4, 2022

 

---